⚒️War Room 1985⚒️ - New Portfolio

Metodo Insider

⚒️War Room 1985⚒️
Individual Investor
Ranked #56,758 out of 765,504 TipRanks' Investors
Success Rate
51%
249 out of 484
profitable transactions
Average Return
56.75%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 8.25%
6-Month Return▲ 15.78%
12-Month Return▲ 269.43%
YTD Return▲ 197.88%
Total Return▲ 533.94%

Best Trade

Opened at
Closed at-
Gain▲ 1538.92%

Bio

Método Insiders por José Ricaurte Jaén Provincia de Colón, República de Panamá

Performance

25.72%0-25.72%
▼ 12.40%
▼ 4.03%
▼ 7.97%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 3.87%
May 2024
▼ 2.25%
▲ 3.53%
▲ 1.77%
Jun 2024
▲ 25.72%
▲ 1.21%
▲ 8.18%
Jul 2024
▼ 4.21%
▲ 2.34%
▼ 1.64%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 0.47%
Sep 2024
▲ 6.02%
▼ 0.89%
▲ 1.11%
Oct 2024
▲ 12.58%
▲ 1.42%
▲ 5.47%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%▼ 7.97%
▲ 11.46%▲ 5.06%▲ 3.87%
▼ 2.25%▲ 3.53%▲ 1.77%
▲ 25.72%▲ 1.21%▲ 8.18%
▼ 4.21%▲ 2.34%▼ 1.64%
▲ 7.82%▲ 2.10%▲ 0.47%
▲ 6.02%▼ 0.89%▲ 1.11%
▲ 12.58%▲ 1.42%▲ 5.47%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Shift Technologies
▼ 99.96%
2
Close
Oct 14, 2024
Vector Group
▲ 168.21%
2
Close
Oct 04, 2024
Southwestern Energy
▲ 127.88%
2
Close
Sep 30, 2024
Audacy
▼ 99.62%
2
Close
Sep 30, 2024
Expand Energy
0.69%
▲ 12.29%
1
Open
Sep 30, 2024
Vapotherm
▼ 99.08%
2
Close
Sep 20, 2024
G1 Therapeutics
▼ 48.11%
2
Close
Sep 17, 2024
Cerevel Therapeutics Holdings
▲ 341.22%
2
Close
Jul 31, 2024
Inhibrx
▲ 85.78%
2
Close
May 30, 2024
Inhibrx Biosciences Inc
0.07%
▲ 1.20%
1
Open
May 30, 2024
Merrimack Pharmaceuticals
▲ 141.67%
2
Close
May 17, 2024
Endo International
▼ 99.76%
2
Close
May 02, 2024
NGM Biopharmaceuticals
▼ 91.64%
2
Close
Apr 08, 2024
Calithera Bio
▼ 99.97%
2
Close
Apr 05, 2024
iMedia Brands
▼ 99.85%
2
Close
Apr 02, 2024
Kinnate Biopharma
▼ 94.09%
2
Close
Apr 02, 2024
Karuna Therapeutics
▲ 338.72%
2
Close
Mar 15, 2024
Orchard Therapeutics
▼ 66.19%
2
Close
Jan 24, 2024
Mirati Therapeutics
▼ 64.91%
2
Close
Jan 22, 2024
Oncorus
▼ 99.19%
3
Close
Dec 29, 2023